K&F’s first post-pandemic jury trial resulted in a $10.6 million verdict for the widow of a mesothelioma victim.

Food and drug administration announces another drug recall

On Behalf of | Mar 22, 2019 | Pharmaceutical Litigation

The last couple of years have been challenging ones for people here in Ohio and elsewhere who suffer from high blood pressure. Numerous medications for this condition are under recall, and the Food and Drug Administration recently announced yet another one. This recall comes from Legacy Pharmaceutical Packaging, LLC. 

The recall consists of three lots of the company’s 30-count bottles of 50 mg Losartan Potassium USP tablets. Doctors across the country, including here in Ohio, prescribe this medication for congestive heart failure and high blood pressure. Trace amounts of N-Nitroso N-Methyl 4-amino butyric acid, a human carcinogen, were detected in one of the medication’s active ingredients, which is manufactured by another company, Hetero Labs Limited.

Legacy is attempting to inform customers and distributors of the recall. Inmar Pharmaceutical Services will receive all of the recalled medication, which was distributed across the country. Consumers are urged to contact this company with any questions and to arrange a return. However, patients should consult with their doctors right away if they take this medication since simply stopping it could prove harmful. This is part of the risk of pharmaceutical recalls since patients often cannot just discontinue using a certain medication, which could put them in further jeopardy.

With all of the recent recalls announced by the Food and Drug Administration for high blood pressure medication, it could only be a matter of time before some people suffer serious health consequences due to the negligence of the pharmaceutical industry. When people suffer injuries or illnesses because they trusted the medications given to them were safe. Fortunately, victims and their families in the case of death could pursue restitution from the appropriate parties through the civil court system.

Archives

$120 Million Settlement

To 15,000 Asbestos Victims

$20 Million Verdict

Mesothelioma

$17 Million Verdict

Mesothelioma

$8.2 Million Verdict

Mesothelioma

White Paper Read Now2
White Paper Read Now